Rutgers Health-New Jersey Medical School Program

Program Identity & Fit

This is an academic, five-year integrated vascular surgery residency within Rutgers-New Jersey Medical School and RWJBarnabas Health, rotating trainees across four distinct hospital environments - a Level 1 trauma/quaternary academic center (University Hospital), a high-volume cardiac/transplant quaternary center (Newark Beth Israel), a large teaching hospital (Cooperman Barnabas), and a community-based Level 2 trauma site (Jersey City Medical Center) where residents build community-practice skills. The division has a long research pedigree, having originated the CREST trial and currently participating in NIH-funded multicenter trials (BEST-CLI) and device studies (HAV grafts, IVC filters), with faculty-led site-PI roles giving residents exposure to structured clinical trial infrastructure. Training emphasizes full-spectrum open and complex endovascular exposure (FEVAR, TCAR, hybrid-room cases) and progressive autonomy, including a resident/fellow-run vascular clinic under faculty supervision. The program's breadth across quaternary academic and community sites, combined with active trial involvement, signals a value for trainees who can function across both complex tertiary referral care and community-based practice building.